Join the Fight

Join the Fight

Together, we are stronger than this disease

Learn how you can take action and get involved with the National Brain Tumor Society. Your participation and support is vital to our mission, and will make a difference in the lives of all those affected. Join us in the fight today.

Find or Start an Event

Find or Start an Event

You can make a difference in the fight against brain tumors by participating in our walks, races, and rides across the country or hosting your own community event.

Make a gift

Make a gift

Support promising research initiatives to improve the lives of the nearly 700,000 Americans living with brain tumors today, and advance the fight for a cure.

Lend your voice

Lend your voice

The critical needs of the brain tumor community must be heard. Learn how to educate your elected officials and policymakers.

From the Blog

  1. November 25, 2014

    Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology

    The Society for Neuro-Oncology (SNO) Annual Scientific Meeting is a multi-day conference that serves as one of the most important gatherings in the field of brain tumor research and drug development. Over three days, presentations are given on some of the most promising research efforts in the field, as well as critical updates on many […]

    Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology Read more | 
  2. November 20, 2014

    Guest Blog: Why I want you to join us on Dec. 2

    August 10, 2010, was a Tuesday. I got confirmation that what my mind and body had been telling me for months, was true. I had a brain tumor. It was a gift that I got the care I needed, and am here today. I got involved with the National Brain Tumor Society to connect with […]

    Guest Blog: Why I want you to join us on Dec. 2 Read more | 
  3. November 17, 2014

    Encouraging Results from Novocure Clinical Trial

    Novocure, a company that creates medical devices to treat cancer, announced this weekend that their Novo-TTF-100A system (now being called Optune), in combination with temozolomide (also know as Temodar or TMZ), demonstrated improved survival in newly diagnosed glioblastoma multiforme (GBM) patients in a clinical trial, compared with temozolomide alone. The announcement was made at the […]

    Read more | 
More from the blog